In the past week, CLS stock has gone down by -5.03%, with a monthly gain of 2.62% and a quarterly plunge of -13.63%. The volatility ratio for the week is 2.76%, and the volatility levels for the last 30 days are 5.26% for Celestica, Inc. The simple moving average for the past 20 days is 1.35% for CLS’s stock, with a 18.66% simple moving average for the past 200 days.
Is It Worth Investing in Celestica, Inc. (NYSE: CLS) Right Now?
The price-to-earnings ratio for Celestica, Inc. (NYSE: CLS) is above average at 16.76x, Company’s 36-month beta value is 2.30.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 9 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CLS is 118.33M, and currently, short sellers hold a 3.11% ratio of that floaft. The average trading volume of CLS on August 27, 2024 was 2.28M shares.
CLS) stock’s latest price update
Celestica, Inc. (NYSE: CLS)’s stock price has soared by 0.61 in relation to previous closing price of 51.00. Nevertheless, the company has seen a loss of -5.03% in its stock price over the last five trading days. globenewswire.com reported 2024-08-27 that – CLS-AX is a Highly Potent Tyrosine Kinase Inhibitor Delivered Suprachoroidally Using Clearside’s Proprietary SCS Microinjector ® –
Analysts’ Opinion of CLS
Many brokerage firms have already submitted their reports for CLS stocks, with Fox Advisors repeating the rating for CLS by listing it as a “Overweight.” The predicted price for CLS in the upcoming period, according to Fox Advisors is $60 based on the research report published on May 15, 2024 of the current year 2024.
CLS Trading at -5.77% from the 50-Day Moving Average
After a stumble in the market that brought CLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.18% of loss for the given period.
Volatility was left at 5.26%, however, over the last 30 days, the volatility rate increased by 2.76%, as shares surge +4.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.02% lower at present.
During the last 5 trading sessions, CLS fell by -5.16%, which changed the moving average for the period of 200-days by +105.29% in comparison to the 20-day moving average, which settled at $50.74. In addition, Celestica, Inc. saw 75.24% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CLS
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.1 for the gross margin
The net margin for Celestica, Inc. stands at 0.04. The total capital return value is set at 0.18. Equity return is now at value 20.99, with 6.43 for asset returns.
Based on Celestica, Inc. (CLS), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.59. The debt to equity ratio resting at 0.41. The interest coverage ratio of the stock is 7.3.
Currently, EBITDA for the company is 569.05 million with net debt to EBITDA at 0.74. When we switch over and look at the enterprise to sales, we see a ratio of 0.75. The receivables turnover for the company is 4.63for trailing twelve months and the total asset turnover is 1.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.47.
Conclusion
In a nutshell, Celestica, Inc. (CLS) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
